Rodrigo E. Mendes - Concepedia

Author

Rodrigo E. Mendes

Also Known As

MENDES, R., Mendes, Rodrigo, R E Mendes, R. E. Mendes, R. Mendes, R.E. Mendes, RODRIGO E. MENDES, RODRIGO MENDES, Ricardo Evandro Mendes, Rodrigo E Mendes

546

Publications

13.3K

Citations

H-Index

109

Concepts

All Affiliations

JMI Laboratories Tufts University University of Iowa Universidade Federal de São Paulo Pfizer (United States)

About

Rodrigo E. Mendes is an author at JMI Laboratories specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	94	4.1K
2	Health Sciences	30	53	2.4K
3	Natural Sciences	2	2	67
4	Engineering	1	1	44
5	Humanities	1	1	25

Rodrigo E. Mendes

225

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo E. Mendes, Antimicrobial Agents and Chemotherapy	2019	612
Early Dissemination of NDM-1- and OXA-181-Producing <i>Enterobacteriaceae</i> in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 Mariana Castanheira, Lalitagauri M. Deshpande, Dilip Mathai, Antimicrobial Agents and Chemotherapy	2010	351
Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis Rodrigo E. Mendes, Katia A. Kiyota, Jussimara Monteiro, Journal of Clinical Microbiology	2006	292
First Report of <i>cfr</i> -Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States Rodrigo E. Mendes, Lalitagauri M. Deshpande, Mariana Castanheira, Antimicrobial Agents and Chemotherapy	2008	226
Transferable Plasmid-Mediated Resistance to Linezolid Due to <i>cfr</i> in a Human Clinical Isolate of Enterococcus faecalis Lorena Díaz, Pattarachai Kiratisin, Rodrigo E. Mendes, Antimicrobial Agents and Chemotherapy Microbial PathogensPathologyDna SequencesAntibiotic ResistanceBacterial Pathogens	2012	184
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program Hélio S. Sader, Ana Cristina Gales, Michael A. Pfaller, The Brazilian Journal of Infectious Diseases	2001	180
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae Mariana Castanheira, Michael D. Huband, Rodrigo E. Mendes, Antimicrobial Agents and Chemotherapy	2017	165
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program Rodrigo E. Mendes, Jan Bell, John Turnidge, Journal of Antimicrobial Chemotherapy	2008	163
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program Mariana Castanheira, Lalitagauri M. Deshpande, Rodrigo E. Mendes, Open Forum Infectious Diseases	2019	163
Detection of a New <i>cfr</i> -Like Gene, <i>cfr</i> (B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program Lalitagauri M. Deshpande, Deborah Ashcraft, Heather P. Kahn, Antimicrobial Agents and Chemotherapy	2015	158

Page 1